Evidence map›Paper›PMID 42014977›Full record

ArticleBMC plant biology2026

Identification of promising sweet sorghum advanced lines for bioenergy production under Mediterranean conditions.

Birgul Guden

Abstract read
In one paragraph

Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Birgul GudenDepartment of Field Crops, Faculty of Agriculture, Akdeniz University, Antalya, Türkiye. birgulguden@akdeniz.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSweet sorghum (Sorghum bicolor L. Moench) is one of the most important renewable bioenergy crops that have high biomass production capacity and high sugar content in stems. The aim of this study was to identify promising lines derived from a recombinant inbred population with greater potential for bioenergy in Mediterranean conditions through an initial, line-level evaluation under the target environment.

resultsTwenty-four genotypes derived from a recombinant inbred line (RIL) population were evaluated during the growing seasons of 2021 and 2022 under Mediterranean field conditions. These lines were derived from crossing “Erdurmus” (sweet sorghum) with “Ogretmenoglu” (grain sorghum). There was significant genotypic variation for all bioenergy-related traits, including plant height (PH), stem diameter (SD), fresh biomass yield (FBY), stem yield (SY), Brix (BX), and plant juice content (JC). Heritability varied from 0.17 for JC to 0.91 for PH. The high values for PH and BX indicate strong genetic effects, and the positive correlations between PH, FBY, and SY show that these traits can be beneficial for selection when evaluated in combination. Principal component and cluster analyses classified genotypes that had greater potential for producing more biomass and sugar and revealed distinct trait-based groupings among lines. Several lines, particularly Srg174, Srg334, and Srg351, performed better than the check cultivars for one or more bioenergy-related traits under the conditions of this study.

conclusionThese lines can be helpful for breeding because they can be used for developing high-yielding cultivars with promising performance under Mediterranean conditions for sustainable bioenergy production and represent valuable genetic material for further advancement in bioenergy-oriented sorghum breeding programs.

Indexed as

BiofuelsSorghumBiomassGenotypeMediterranean RegionPlant BreedingBiofuelsBiomassBrixJuice contentPlant height

Identifiers

PMID42014977
PMCPMC13231742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.